Eagle Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
STANLEY-LAMAN GROUP, LTD. | 04/16/2025 | 12.00 K | $11.76 K | 0.00% | 0.09% |
ARCHER INVESTMENT CORP | 05/05/2025 | 350 | $343 | 0.00% | 0.00% |
BARCLAYS PLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 0 | $0 | -100.00% | 0.00% |
CREDIT AGRICOLE S A | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
SIMPLEX TRADING, LLC | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
RUSSELL INVESTMENTS GROUP, LTD. | 05/13/2025 | 0 | $0 | -100.00% | 0.00% |
XTX TOPCO LTD | 05/08/2025 | 0 | $0 | -100.00% | 0.00% |
FARTHER FINANCE ADVISORS, LLC | 04/14/2025 | 0 | $0 | -100.00% | 0.00% |
Eagle Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 77 institutional investors and hedge funds held shares of Eagle Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Stanley-Laman Group, Ltd.: 12,000
Archer Investment Corp: 350
ACADIAN ASSET MANAGEMENT LLC: 0
BARCLAYS PLC: 0
Russell Investments Group, Ltd.: 0
SIMPLEX TRADING, LLC: 0
0.09% of Eagle Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 3.52 M shares in the last 24 months. This purchase volume represents approximately $10.56 M in transactions.